EnginZyme is a biotechnology company that specializes in biocatalysis.

2021-02-11 · EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden.

Athera (company). Athera Biotechnologies researches and develops pharmaceutical solutions for risk assessment and treatment of cardiovascular diseases. Arctic15 is the most effective matchmaking and networking event in the Nordics for startups, businesses and investors since 2011. Feb 17, 2021 The Industrifonden-led tranche has helped the Stockholm spinout lift the round to $13.3m, which will be used to conduct a proof-of-concept run. Feb 11, 2021 The extension round was driven by Industrifonden, Sweden's deep tech funding firm, followed by SEB Greentech VC and existing shareholders The extension round was driven by Industrifonden, Sweden's deep tech funding firm, followed by SEB Greentech VC and existing shareholders. “Current bio- EnginZyme is a biotechnology company that focuses on enzyme immobilization, they EnginZyme raises a $5,300,000 series A round from Industrifonden. Feb 14, 2021 This page provides investment and traction data on EnginZyme, a Developer of a cell-free synthetic biology platform for production of 2021年2月11日 EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and We're funded by Sofinnova Partners, Industrifonden and SEB Greentech VC, and employ some of the best researchers in their respective fields.

Early-stage; 12 February 2021. Stiftelsen Industrifonden, doing business as Industrifonden, operates as a venture capital firm. The Company invests in business, consumer technology and life Dec 17, 2020 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden. EnginZyme Extends Series A Feb 11, 2021 EnginZyme (the three founders Robin Chatterjee, Karim Engelmark where SEB Greentech and Industrifonden is participating along with Rundan leds av Industrifonden, Sveriges största venture capitalfirma inom deep tech, och inkluderar även SEB Greentech VC samt existerande Karim Engelmark Cassimjee, som har grundat Enginzyme tillsammans med Robin Bolaget får nu in Industrifonden som ny storägare. Den statligt grundade stiftelsen Industrifonden ledde en finansieringsrunda i Enginzyme, som utvecklar en teknisk plattform för hållbar EnginZyme AB - Paving the way to cell free synthetic biology, the next Director of Enzyme Engineering at EnginZyme Deep Tech VC at Industrifonden. EnginZyme is a Swedish startup founded in 2014 that has developed a platform for sustainably producing both the current building blocks of the world — the I höstas var Enginzyme med på Ny Tekniks 33-listan som ett av Sveriges bästa unga teknikbolag. Nu tar bolaget in 111 miljoner bland annat från Industrifonden.

EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised EnginZyme is developing a novel technology platform to support the assembly and deployment of biological factories based on enzymes for the production of chemicals.

EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden Read full article February 10, 2021, 10:00 PM · 4

Den statligt grundade stiftelsen Industrifonden ledde en finansieringsrunda i Enginzyme, som utvecklar en teknisk plattform för hållbar produktion av kemikalier. Det framgår av ett pressmeddelande.

EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden

EnginZyme is developing a novel technology platform to support the assembly and deployment of biological factories based on enzymes for the production of chemicals. With its biomimicking approach of production, EnginZyme achieves stellar productivity without compromising on the impact on climate or the finite resources of Earth. EnginZyme utvecklar en ny teknikplattform för konstruktion och driftsättning av biologiska fabriker baserade på enzymer för produktion av kemikalier. EnginZymes teknologi medför hög produktivitet utan att kompromissa på klimatpåverkan eller jordens finita resurser. To summarize, Industrifonden is very happy to join team EnginZyme in bringing about a new paradigm for the chemical industry and we truly look forward to working with the team to realize the true potential of EnginZyme.

Resources. Resources. Pricing. Log In. Organization. EnginZyme.
När ska momsen betalas kvartal

Industrifonden leads €4.6m extended series-A for EnginZyme Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million. The extension round was led by Industrifonden, Sweden’s largest deep tech venture capital firm, followed by SEB Greentech VC and existing shareholders.

EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden.
Örebro studentliv

vilket av följande ämne bidrar mest till växthuseffekten
sak 215 replacement
gulag arkipelagen svenska
nominella diametern
filips gatukök
byggnads semester avtal
rock of ages kristianstad biljetter

Feb 17, 2021 The Industrifonden-led tranche has helped the Stockholm spinout lift the round to $13.3m, which will be used to conduct a proof-of-concept run.

– Bolaget är i slutfasen av att bekräfta sin teknologi med fyra olika produkter så vi kommer in i en spännande fas, säger Markus Hökfelt, chef för SEB Greentech, i … STOCKHOLM--(BUSINESS WIRE)-- EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million.The extension round was led by Industrifonden, Sweden’s largest deep tech venture capital firm, followed by SEB Greentech VC and existing shareholders. 2021-02-11 Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture - #private-equity #HedgeMaven February 11, 2021 01:00 AM Eastern Standard Time STOCKHOLM--(BUSINESS WIRE)--EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million.The extension round was led by Industrifonden, Sweden’s largest deep tech venture capital firm EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art chemical processing techniques "EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency," said Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million.

Frisq holding ab
svenska poeter män

Det svenska bolaget Enginzyme vill byta ut tungmetaller i framställningen av de flesta olika produkter mot naturliga enzymer, som finns i våra celler. Bolaget får nu in Industrifonden som ny storägare.

Industrifonden is an early stage venture capital fund. Based in Sweden, we have a reach across the Nordics. We look for transformative ventures that define the industries of tomorrow.

Industrifonden. • Almi Invest AB. • Innovationsbron AB (inordnades 2013 i Almi Enginzyme AB. Stayble Therapeutics AB. European Institute Of Science AB.

Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden. 1, Industrifonden · Funnel, Flexenclosure, Calliditas Therapeutics , [+36]. 2, Creandum · Voi 79, Sofinnova Partners · EnginZyme. 80, Mosaic Industrifonden. • Almi Invest AB. • Innovationsbron AB (inordnades 2013 i Almi Enginzyme AB. Stayble Therapeutics AB. European Institute Of Science AB. EnginZyme is seeking a Chief Financial Officer to lead the company's We're funded by Sofinnova Partners, Industrifonden and SEB Greentech VC, and The Swedish biotechnology company EnginZyme AB has completed inter alia Stiftelsen Industrifonden and Acacia Asset Management AB. About: #Enginzyme #Foundation Industrifonden · 360° Overview · Kyrkan var en prolife-rörelse redan från början · Politics 13 hours ago dagen.se Industrifonden investerar i banbrytande teknologier och SEB Greentech VC SEB Greentech investerar i Enginzyme i 11 miljoner euro-runda.

We aim to 11 feb 2021 Rundan leds av Industrifonden, Sveriges största venture capitalfirma inom deep tech, och inkluderar även SEB Greentech VC samt existerande Feb 10, 2021 EnginZyme is on a mission to transform the $5 trillion chemical The extension round was led by Industrifonden, Sweden's largest deep tech Announcing Industrifonden's investment into EnginZyme's EUR 11M Series A. February 10, 2021. For some time now the Industrifonden team has been Cellink to Acquire Ginolis for €70m in Cash & Shares · EnginZyme Extends Series A to €11m, Led by Industrifonden · Evaxion Biotech A/S Closes $30m US David Sonnek. CEO, Industrifonden Karim Engelmark Cassimjee. CEO, EnginZyme Karim Engelmark Cassimjee. CEO, EnginZyme Patrick Sobocki.